US Patent Issued to Novocure on Aug. 25 for "Methods of reducing ciliogenesis with alternating electric fields" (American, Israeli Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,716,887, issued on Aug. 25, was assigned to Novocure GmbH (Baar, Switzerland).

"Methods of reducing ciliogenesis with alternating electric fields" was invented by Matthew R. Sarkisian (Gainesville, Fla.), Lilach Avigdor (Haifa, Israel) and Preshita Desai (Pomona, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of determining susceptibility of cancer cells to treatment with alternating electric fields, or of reducing the viability of cancer cells by applying alternating electric fields, by measuring percentage of ciliated cancer cells or by measuring average length of a primary cilia of cancer cells. A method of treating Huntington's disea...